BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/28/2019 9:29:28 AM | Browse: 721 | Download: 1163
 |
Received |
|
2019-09-29 15:53 |
|
Peer-Review Started |
|
2019-09-29 15:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2019-11-10 05:37 |
|
Revised |
|
2019-11-27 05:29 |
|
Second Decision |
|
2019-12-12 10:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-12-13 01:24 |
|
Articles in Press |
|
2019-12-13 01:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-12-24 02:14 |
|
Typeset the Manuscript |
|
2019-12-27 08:21 |
|
Publish the Manuscript Online |
|
2019-12-28 09:29 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yong-Lian Zeng, Zhen-Ya Guo, Hui-Zhao Su, Fu-Di Zhong, Ke-Qing Jiang and Guan-Dou Yuan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guan-Dou Yuan, MSc, Director, Director, Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. yuan25958282@163.com |
| Key Words |
LncRNA Cancer susceptibility candidate 9; Hepatocellular carcinoma; Prognosis; Kyoto Encyclopedia of Genes and Genomes; Gene ontology; CeRNA |
| Core Tip |
Previous studies have found that lncRNA Cancer susceptibility candidate 9 (CASC9) can promote the survival of hepatocellular carcinoma (HCC) cells through AKTions, but it is not clear whether lncRNA CASC9 can be used as a clinical diagnosis and prognosis indicator for patients with HCC. This study has confirmed that lncRNA CASC9 can be used as a potential prognostic and diagnostic indicator for patients with HCC and it may be a potential therapeutic target for HCC. |
| Publish Date |
2019-12-28 09:29 |
| Citation |
Zeng YL, Guo ZY, Su HZ, Zhong FD, Jiang KQ, Yuan GD, Diagnostic and prognostic value of lncRNA Cancer susceptibility candidate 9 in hepatocellular carcinoma. World J Gastroenterol 2019; 25(48): 6902-6915 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i48/6902.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i48.6902 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
